During development, cells interpret complex and often conflicting signals to make optimal decisions. Plant stomata, the cellular interface between a plant and the atmosphere, develop according to positional cues, which include a family of secreted peptides called epidermal patterning factors (EPFs). How these signalling peptides orchestrate pattern formation at a molecular level remains unclear. Here we report in Arabidopsis that Stomagen (also called EPF-LIKE9) peptide, which promotes stomatal development, requires ERECTA (ER)-family receptor kinases and interferes with the inhibition of stomatal development by the EPIDERMAL PATTERNING FACTOR 2 (EPF2)-ER module. Both EPF2 and Stomagen directly bind to ER and its co-receptor TOO MANY MOUTHS. Stomagen peptide competitively replaced EPF2 binding to ER. Furthermore, application of EPF2, but not Stomagen, elicited rapid phosphorylation of downstream signalling components in vivo. Our findings demonstrate how a plant receptor agonist and antagonist define inhibitory and inductive cues to fine-tune tissue patterning on the plant epidermis.
Development and pattern formation of multicellular organisms rely on diffusible signals that instruct cells to adopt a specific fate for optimal function, and hence organismal fitness. Often such signals are encoded by multiple gene families, which raises the question of how a given cell orchestrates the decision-making process. For instance, a family of secreted signals, such as FGFs, are used in an iterative manner to specify multiple, diverse developmental processes in animals 1 . While peptide signalling has recently emerged as a critical regulator of plant development 2 , how specific members of plant peptide families share and distribute functions remains unclear. Patterning of stomatavalves on the plant epidermis that mediate carbon dioxide acquisition and water control-relies on cell-cell communication, which specifies a subset of seemingly uniform protodermal cells to acquire stomatal progenitor fate. Two secreted cysteine-rich peptides, EPF1 and EPF2, are expressed in later and earlier stages of stomatal precursors, respectively, and are perceived by the cell-surface receptors, ER-family leucine-rich repeat receptor kinases (LRR-RKs)-ER, ER-LIKE1 (ERL1) and ERL2-to inhibit stomatal development [3] [4] [5] [6] [7] . The receptor-like protein TOO MANY MOUTHS (TMM) modulates the signalling strengths of ER-family receptor kinases in a region-specific manner 6, 8 . Genetic evidence suggests that the signals are mediated via a mitogen-activated protein kinase (MAPK) cascade, which eventually downregulates the transcription factor responsible for initiating stomatal lineage via direct phosphorylation 9-12 . Recently, EPF-LIKE9 (EPFL9) peptide, also known as Stomagen, was identified as a positive regulator of stomatal development, a role opposite to . Structural modelling of the EPF/ EPFL-family peptides using the NMR-solved structure of Stomagen predicts that they all adopt related structures 16 . This raises the question of how can structurally related peptides confer completely opposite developmental responses. The molecular mechanism for Stomagen action remains unknown.
Stomagen acts downstream of the ER family
To place Stomagen into a genetic framework of the core stomatal signalling pathway, we first examined the effects of induced STOMAGEN overexpression (iSTOMAGEN) on er erl1 erl2 triple mutant phenotypes by an oestradiol-induction system or co-suppression by artificial microRNA (STOMAGEN-ami) ( Fig. 1 and Extended Data Figs 1-4). As previously reported 13, 14 , ectopic iSTOMAGEN expression resulted in an increase in stomatal density (number of stomata per mm 2 ), stomatal index (percentage of stomata per total number of stomatal and nonstomatal epidermal cells) and severe stomatal clustering in wild-type cotyledon epidermis ( Fig. 1a, b , k and Extended Data Figs 1-3). In contrast, iSTOMAGEN had no effect on stomatal density, stomatal index, or stomatal clusters in er erl1 erl2 cotyledons, just like in tmm ( Fig. 1 and Extended Data Fig. 3) 13, 14 , suggesting that STOMAGEN and the ER family act in the same pathway.
As reported, STOMAGEN-ami lines markedly reduced stomatal development in wild-type cotyledons (Fig. 1a, c, j and Extended Data Fig. 4) 13 . In contrast, STOMAGEN-ami had no effect on stomatal density, stomatal index, and stomatal clustering phenotype of er erl1 erl2 cotyledons, just like tmm ( Fig. 1 and Extended Data Fig. 4) . Thus, ER-family receptor kinases are required for the hypermorphic and hypomorphic effects of Stomagen. The epistasis of er erl1 erl2 stomatal cluster phenotype over the phenotype of STOMAGEN-ami places the ER family downstream of STOMAGEN, consistent with the molecular identity of their gene products as receptor kinases and a secreted peptide.
Genetic dissection of Stomagen action
To dissect the role of Stomagen on the TMM and ER module, we comprehensively investigated the effects of iSTOMAGEN on stomatal differentiation in tmm hypocotyls with additional er-family mutations ( Fig. 2 and Extended Data Fig. 5 ). In hypocotyls, TMM and ER family have opposite functions: tmm hypocotyls lack stomata 18 , whereas er erl1 erl2 hypocotyls produce stomatal clusters 19 . While tmm is epistatic to er single mutation in hypocotyls, consecutive loss of ER-family genes reverts stomatal development in a dosagedependent manner, with er erl1 erl2 being epistatic to tmm ( 13 . However, in some instances arrested stomatal precursor cells (stomatal-lineage ground cells (SLGCs)) were observed, indicating that, in the absence of TMM, iSTOMAGEN could initiate stomatal development in hypocotyls ( Fig. 2a, b and Extended Data Fig. 5c, d ). Additional er-family mutations exaggerated this effect; that is, iSTOMAGEN in tmm er and tmm erl2 hypocotyls, both of which lack stomata, resulted in SLGC clusters (Fig. 2c, . iSTOMAGEN triggered stomatal cluster formation in tmm erl1, tmm erl1 erl2 and tmm er erl1 mutant hypocotyls, while intensifying stomatal entry divisions in tmm er erl2 hypocotyls (Fig. 2e, . Different effects of iSTOMAGEN on the higher-order mutants lacking ER (for example, tmm er and tmm er erl2) compared with those lacking ERL1 (for example, tmm erl1 and tmm erl1 erl2) reflect the overlapping yet unique roles of ER and ERL1 in stomatal development 6 . Finally, iSTOMAGEN failed to enhance the severe stomatal clustering phenotype in tmm er erl1 erl2 mutants (Fig. 2g, h and Extended Data Fig. 5q, r) . Quantitative analysis of stomatal index and SLGC index (the percentage of SLGCs in total epidermal cells) supports these findings (Extended Data Fig. 5s, t) . Together, the results suggest that in the hypocotyls, where TMM and ER-family act antagonistically, Stomagen primarily acts via all three ER-family receptor kinases.
Among the ER family, ER primarily perceives EPF2 to restrict initiation of stomatal cell lineages, while ERL1 primarily perceives EPF1 to orient stomatal spacing and prevent guard cell differentiation 6 . As such, epf2 increases SLGCs, whereas epf1 violates stomatal spacing 3-5 . Neither epf2 nor epf1 confers severe stomatal clustering phenotype like iSTOMAGEN, since only a subset of ER-familymediated pathways has been compromised 6 . We delineated the role of Stomagen in each of these steps. We first examined whether EPF1, EPF2 and STOMAGEN transcripts are under feedback regulation, which may complicate the genetic analyses. EPF1 and EPF2 transcript levels were slightly upregulated by iSTOMAGEN, and conversely, slightly downregulated by STOMAGEN-ami (Extended Data Fig.  2c, d) . However, the endogenous STOMAGEN transcript levels are unaffected by epf1, epf2, or epf1 epf2 (Extended Data Fig. 2d ). Thus, altered expression of EPF1 and EPF2 by STOMAGEN misregulation probably reflects the numbers of stomatal-lineage cells 13, 14 .
EPF2-ER or EPF1-ERL1 signalling pathways with iSTOMAGEN resulted in severe stomatal clusters, indicating that excessive Stomagen promotes stomatal differentiation when either pathway is compromised (Extended Data Fig. 3 ). These genetic data support the notion that Stomagen, when ectopically overexpressed, can bind to all ER-family receptor kinases and inhibit signal transduction. Indeed, co-immunoprecipitation experiments using Nicotiana benthamiana microsomal fraction expressing green fluorescent protein (GFP)-fused ectodomains of ER, ERL1, ERL2 or TMM incubated . Images were taken under the same magnification. Scale bar, 30 mm. n 5 13 (a); n 5 18 (b); n 5 26 (c); n 5 16 (d); n 5 24 (e); n 5 26 (f); n 5 16 (g); n 5 24 (h); n 5 12 (i). with synthetic Stomagen peptides demonstrated that Stomagen associates with all ER-family receptor kinases and TMM (Extended Data Fig. 6a ). Unlike overexpression, Stomagen co-suppression imposed different effects on EPF2-ER and EPF1-ERL1 signalling pathways. STOMAGEN-ami suppressed the stomatal-pairing phenotype of epf1 and dominant-negative, kinases-deleted ERL1 (ERL1(DK)) erl1 (Extended Data Fig. 4g -j, m). In contrast, STOMAGEN-ami exhibited complex interactions with epf2 and dominant-negative ER (ER(DK)) er, reducing numbers of stomata but not that of SLGCs (Extended Data Fig. 4c -f, k-n). This supports the idea that Stomagen counteracts EPF2 for ER-mediated stomatal initiation 13, 14, 16 . This also suggests that, in the absence of both EPF2 and STOMAGEN, the default ER pathway is not activated while the later ERL-mediated pathway remains capable of repressing the differentiation of mature stomata.
Competitive binding of EPF2 and Stomagen
A series of genetic analyses leads to the possibility that Stomagen antagonizes EPF2's action via direct binding to ER. To address this, we produced bioactive Stomagen and predicted mature EPF2 (mEPF2) peptides (Extended Data Figs 7 and 8). Subsequently, their direct binding to ER as well as to TMM was tested using previously established quartz crystal microbalance (QCM) biosensor platforms ( Fig. 3a, b and Extended Data Fig. 9 ) 6 . Briefly, we immobilized purified GFP-fused receptors or control GFP from N. benthamiana on gold surfaces of QCM chips via anti-GFP antibody and then introduced the bioactive Stomagen or mEPF2 peptide solutions. The peptide-receptor binding was recorded as a function of frequency change (see Methods) 6 . Both Stomagen and mEPF2 exhibited saturable binding to the ER ectodomain fused to GFP (ER(DK)-GFP) with similar dissociation constants at a nanomolar range ( Fig. 3a, b and Extended Data Fig. 9 ). Additionally, Stomagen and mEPF2 bound to TMM with high affinity (Fig. 3a, b ). No significant binding of Stomagen or mEPF2 to control GFP was detected ( Fig. 3a, b and Extended Data Fig. 9 ). To address the specificity of peptide-receptor interactions, two control peptides were subjected to the QCM analysis using ER(DK)-GFP-functionalized chips: (1) non-folding, inactive mutant Stomagen, in which six cysteines were substituted with serines (Extended Data Fig. 8g ) 16 ; and (2) LURE2, an unrelated cysteine-rich peptide, which acts as a pollen-tube attractant 20 . Neither mutant Stomagen nor LURE2 exhibited binding above the background level ( Fig. 3c ). Consistently, LURE2 did not associate with ER, TMM, or an innate immunity receptor FLS2 (refs 21, 22) fused with GFP expressed in N. benthamiana in co-immunoprecipitation assays (Extended Data Stomagen-ER, n 5 3; Stomagen-TMM, n 5 2; Stomagen-GFP, n 5 3; mEPF2-ER, n 5 2; mEPF2-TMM, n 5 3; mEPF2-GFP, n 5 2. c, The average experimental frequency shift values recorded for LURE2 (dark grey) and mutant Stomagen (light grey) on ER(DK)-GFP. To calculate the dissociation constant (K d ) values, the ligand concentrations were increased to 1 mM to obtain fitted curves. See Extended Data Fig. 9 for raw recording data. Inactive mutant Stomagen, in which six cysteines were substituted with serines (Stomagen_C6RS)-ER, n 5 3; LURE2-ER, n 5 2. Error bars indicate s.d. Right insets: wild-type cotyledon epidermis treated with 2.5 mM mutant or bioactive Stomagen. Scale bars, 30 mm. n 5 8 for each treatment. For a-c, each experimental point in independent binding experiment (referred to as 'n 5 1') is generated from multi-point raw data (10-20 points) with average and s.d. values. d, Competitive binding. Microsomal fractions expressing ER(DK)-GFP were incubated with 1 mM of bioactive mEPF2 with increasing concentrations of bioactive Stomagen and subjected to immunoprecipitation. The mEPF2-MYC-His blot was re-probed with anti-Stomagen antibody. Asterisk indicates most likely isomer. e, Quantitative analysis of competition from four biological replicates. Error bars, s.e.m. The IC 50 value is substantially higher than the K d values for Stomagen-ER or mEPF2-ER, presumably owing to the immunoblot-based quantification. f, Wild-type cotyledon epidermis treated with mEPF2 alone or simultaneously co-treated with mEPF2 and increasing concentrations of Stomagen for 5 days. n 5 3 for each treatment. Images were taken under the same magnification. Scale bar, 50 mM. Fig. 6b ). Similarly, FLS2 failed to immunoprecipitate Stomagen above background levels (Extended Data Fig. 6c ). Together, the results emphasize the specificity of Stomagen-ERECTA and Stomagen-TMM interactions. Next, we performed ligand competition assays between Stomagen and EPF2. Microsomal fractions from N. benthamiana expressing ER ectodomain (ER(DK)-GFP) were incubated with bioactive epitope-tagged mEPF2 (mEPF2-MYC-HIS; 1 mM) and increasing concentrations of bioactive Stomagen peptides (0-23.4 mM) followed by immunoprecipitation of ER. Co-immunoprecipitated epitopetagged mEPF2 was detected first. Then, the same blot was re-probed with anti-Stomagen antibody to detect co-immunoprecipitated Stomagen. Increasing concentrations of Stomagen peptide replaced mEPF2 for ER binding (Fig. 3d ). Quantitative analysis confirmed the competitive binding of Stomagen and mEPF2 to ER, with a half-maximum inhibitory concentration (IC 50 ) value of 454 nM (Fig. 3e ). Our results demonstrate that Stomagen and EPF2 peptides directly compete for binding to the same receptor, ER. Application of mEPF2 to wild-type seedlings inhibited stomatal development, while simultaneous treatment of mEPF2 with increasing concentration of Stomagen in a similar concentration range used in the competition experiments resulted in increased stomatal differentiation (Fig. 3f ). The results are consistent with a previous report 16 and further emphasize the in vivo biological relevance of peptide competition.
Activation of downstream signalling
To unravel the mechanism of Stomagen as a competitive antagonist of EPF2, we examined the activation of downstream signalling, specifically, using phosphorylation of MPK3 and MPK6 as readout. Genetic studies suggest that EPF2-ER ligand-receptor signalling acts via a MAPK cascade 9-12 . However, a recent report of co-expressed stomatal signalling components in N. benthamiana failed to detect MPK6 activation by EPF2 (ref. 17) , probably due to a limitation of the heterologous co-expression system for capturing fast and transient response. We therefore tested MAPK activation in vivo using Arabidopsis seedlings. Application of mEPF2 peptide to Arabidopsis wild-type seedlings rapidly elicited phosphorylation of MPK3 and MPK6 in 10 min, a characteristic signature of MAPK activation, which declined after 2 h (Fig. 4a, b ). Heat-induced denaturation of mEPF2 greatly diminished MAPK phosphorylation, correlating with its loss of bioactivity (Fig. 4b, c ). By contrast, Stomagen peptide treatment failed to trigger MAPK phosphorylation ( Fig. 4a ). We conclude that EPF2 activates ER signalling, leading to subsequent MAPK activation to inhibit stomatal development, while Stomagen prevents the signal transduction.
Discussion
Our work elucidates the competitive binding of Stomagen and EPF2 to ER as a molecular mechanism optimizing stomatal patterning. Plant genomes possess large numbers of peptide gene families, the functions of which remain largely unknown 23 . The concept of finetuning signal transduction by related endogenous peptides that assume opposing functions may extend to other peptide families. EPF2 is expressed in a subset of protodermal cells, while Stomagen is secreted from an underlying internal tissue 4, 5, 13, 14 . Thus, it seems plausible that a protodermal cell might respond to differences in intrinsic concentrations of EPF2 and Stomagen on each neighbouring side. It remains to be tested whether local concentrations of Stomagen in the apoplast reflect the IC 50 values we have determined biochemically ( Fig. 3e ). The complex effects of STOMAGEN overexpression on a series of er-family mutants in the tmm background ( Fig. 2 ) resemble that of challah (chal) higher-order mutants, which lack EPFL4 and EPFL6 peptides, another set of ER ligands promoting stem growth [24] [25] [26] . This raises the possibility that complex fine-tuning of multiple EPF-family peptides may occur at developmental contexts far beyond stomatal patterning. Quantitative visualization of each peptide in vivo during epidermal development, as well as precise documentation of the dose-response effects of simultaneous mixed peptide applications of wide concentration gradients, may reveal the signalling complexity at the level of ligand-receptor association. EPF2 and Stomagen bind to ER and TMM with a similar affinity ( Fig. 3 ), suggesting the formation of co-receptor complexes, a hallmark of receptor activation and signal transduction in plant LRR-RKs in development and innate immunity response 27, 28 . Future structural and cell biological studies may reveal the intricacy behind how a cell interprets conflicting signals to make decisions during developmental patterning.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. in Arabidopsis seedlings. a, b, Differential MAPK activation in Arabidopsis wild-type seedlings treated with buffer only (a, mock), mEPF2 (a, b), Stomagen (a), and heat-denatured mEPF2 (b) for respective time intervals (min). The blots were probed with anti-phospho-ERK antibody (anti-pERK) to detect phosphorylated MPK6 (pMPK6) and pMPK3 upon peptide treatment. Asterisk indicates non-specific band. CBB, total proteins stained. Four and two biological replicates were performed for a and b, respectively. c, Confocal microscopy of Arabidopsis wild-type cotyledon abaxial epidermis treated with heat-denatured mEPF2 (top) and control, non-denatured mEPF2 (bottom). Scale bar, 40 mm. n 5 3 for each treatment.
METHODS
No statistical methods were used to predetermine sample size. Plant materials and growth conditions. The Arabidopsis accession Columbia (Col) was used as wild type. All plants used in this study are in the Col background. The following mutants and transgenic plant lines were reported previously: er-105, erl1-2, erl2-1 and their higher order mutants 7 ; tmm-1 (ref. 8); epf1, epf2, epf1 epf2 and tmm- KO (refs 3, 4) ; ER(DK) in er-105, ERL1(DK) in erl1-2 (ref. 6); and STOMAGEN-ami line (line 12; a gift from I. Hara-Nishimura) 13 . The STOMAGEN-ami lines were introduced into various mutant or transgenic backgrounds via genetic crosses. Plants were grown as described previously 29 . For phenotypic analysis, seedlings were grown on 0.5 Murashige and Skoog (MS) media containing 13 Gamborg Vitamin (Sigma), 0.75% Bacto Agar, and 1% w/v sucrose under continuous light condition at 50 mmol s 21 m 22 (light intensity measured by LI-250A; LI-COR). Plasmid construction and transgenic plants generation. pKUT608 (pENTR-STOMAGEN) and pKMP127 (Est::STOMAGEN) were generated. See Extended Data Table 1 for plasmid and primer sequence information. Transgenic Arabidopsis plants were generated by the floral dip method 30 . Multiple transgenic lines per construct were subjected to phenotypic characterization and representative lines (three lines if lines were established, and 12-14 lines if T1 lines were used) were used for quantitative analyses. The Est::STOMAGEN lines were introduced into various mutants or transgenic backgrounds via genetic crosses. Chemical induction of transgene. Transgenic Arabidopsis seedlings carrying Est::STOMAGEN was germinated on 0.5 MS medium supplemented with 10 mM oestradiol (Sigma). Induction of STOMAGEN gene expression (iSTOMAGEN) was confirmed by RT-PCR (see Extended Data Fig. 2) . The induction was further confirmed by observing the epidermal phenotypes of cotyledons and hypocotyls using a confocal microscope. RT-PCR analysis. RNA extraction, cDNA synthesis and RT-PCR were performed as previously described 31 . For a list of primers, see Extended Data Table 1 . Histology, microscopy and image analysis. Confocal microscopy images were taken using either Zeiss LSM700 operated by Zen2009 (Zeiss) described previously 6 or Leica SP5-WLL operated by LAS AF (Leica). Cell outlines were visualized with either propidium iodide (PI: Molecular Probes) or FM4-64 (Invitrogen) and observed using the HyD detector with excitation 515 nm, emission 623-642 nm. The images were false coloured using Photoshop CS6 (Adobe). Clearing of seedlings by chloral hydrate and observation using differential interference contrast (DIC) microscope was performed as described previously 32 . For histological analysis, seedlings were stained with toluidine blue-O (TBO: Sigma) as follows. Briefly, samples were placed in 9:1 v/v ethanol to acetic acid overnight, rehydrated through reduced ethanol series to deionized water, then stained with 0.5% TBO for 3 min. Seedlings were immediately rinsed with deionized water and subsequently mounted in 15% v/v glycerol. For bright-field and DIC microscopy, images were taken under Olympus BX51 equipped with DP73 digital camera operated by CellSens Standard software (Olympus). Quantitative analysis of epidermis. Abaxial cotyledons from 10-day-old seedlings of respected genotypes were subjected to TBO staining or DIC microscopy. The central regions overlying the distal vascular loop were imaged and numbers of epidermal cells, stomata and their cluster size were quantified. For each genotype, sample size of 14-16 was used and over 1,000 epidermal cells were counted to provide statistical robustness. For cotyledons of Est::STOMAGEN lines, individual T1 seedlings were subjected to analysis. For hypocotyls, three representative T2 Est::STOMAGEN lines were analysed. For each seedling, a representative image was taken at the exact location to minimize the variance. Specific numbers of stomata are listed for each genotype in corresponding figure legends. Statistical analysis (Wilcoxon rank sum test) was performed using R version 3.0.3 for stomatal density, stomatal index and SLGC index. P values are indicated in each figure legend. Transient protein expression in Nicotiana benthamiana. Agrobacterium tumefaciens strain GV3101 was transformed with expression clones and grown in yeast extract and beef medium supplemented with relevant antibiotics. Bacterial cultures were precipitated and resuspended in infiltration medium (10 mM MgCl 2 , 10 mM MES (pH 5.6) and 150 mM acetosyringone). Culture densities were adjusted to an OD 600 of 1.0, and the cells were incubated at room temperature for 4 h before infiltration. Equal volumes of cultures carrying different constructs were mixed. To enhance transient expression in tobacco, the silencing suppressor p19 (a gift from D. Baulcombe) was co-infiltrated 33 . The bacterial suspensions were infiltrated into young but fully expanded leaves of N. benthamiana plants. After infiltration, plants were cultivated at 25 uC and collected for further biochemical assays after 48-72 h. Peptide expression, purification and refolding. Recombinant mEPF2 peptide was prepared as reported previously 6 and the mature Stomagen peptide, either wild-type or non-refolding mutant version in which all six cysteines were substituted by serines, were chemically synthesized (Invitrogen and BioSynthesis). The Stomagen peptide was dissolved in 20 mM Tris-HCl, pH 8.8, and 50 mM NaCl and refolded (Mini dialysis kit, MWCO:1,000, GE Healthcare) for 3 d at 4 uC using glutathione (reduced and oxidized forms; Wako) and L-arginine ethyl ester dihydrochloride (Sigma). The peptides were further dialysed three times against 50 mM Tris-HCl, pH 8.0 for 1.5 d to remove glutathione. For non-folding mutant Stomagen, chemically synthesized peptides were dissolved in 50 mM Tris-HCl, pH 8.0. The resulting mEPF2, Stomagen and mutant Stomagen peptides were fractionated using C18 column (Gemini) by HPLC (Waters Delta Prep 3000 HPLC) as previously described to determine the purity of each peptide 6 . The separated peaks were collected, and each peak was identified by MALDI-TOF mass spectrometry on an Autoflex II mass spectrometer in positive ion mode (Bruker Daltonics) using 2:1 a-cyano-4-hydroxycinnamic acid and 2,5dihydroxy-benzoic acid matrix. The collected HPLC-purified mEPF2 and Stomagen peptide peaks were freeze-dried, then re-dissolved to appropriate concentration. Quantification of the active populations of peptides was determined using NanoDrop8000 (Thermo Scientific) using the following molar extinction coefficients: Stomagen, 5,960; EPF2, 6,460; LURE2, 23,950 mol 21 cm 21 . For bioassays, freeze-dried peptides were re-dissolved to appropriate concentration in MS medium. For subsequent biochemical assays, the amounts of bioactive peptides were calculated from this quantification. Peptide bioassays. Refolded recombinant mEPF2 and Stomagen peptides in buffer were applied to 1-day-old Arabidopsis plants that had germinated on 0.5 MS medium. After 5 d of further incubation in 0.5 MS liquid medium containing each peptide (2.5-5 mM concentration), stomatal phenotypes of abaxial cotyledon epidermis were determined by inspection with a confocal microscope as described previously 6 . Immunoprecipitation, protein gel electrophoresis and immunoblots. For immunoprecipitation and co-immunoprecipitation assays, N. benthamiana leaves expressing CaMV35S::ERDK-GFP, CaMV35S::FLS2(DK)-GFP, CaMV35S:: TMM-GFP, CaMV35S::GFP, or empty vector were subjected to protein preparation (microsomal fraction enrichment for all except soluble GFP). Co-incubation with Stomagen (1 mM) or LURE2 peptides (1 mM) and immunoprecipitation procedure are described in the Ligand Competition Assays section below. Immunoprecipitation using either anti-GFP (Abcam ab290) antibodies and protein gel immunoblot (western blot) analysis using anti-GFP (Invitrogen C163), anti-Flag (Sigma-Aldrich M2), anti-His (Qiagen anti-His5 34660), and anti-Stomagen (a gift from I. Hara-Nishimura) 13 antibodies were performed as described previously 6 . As secondary antibodies, either goat anti-mouse (GE Healthcare NA931) or anti-rabbit IgG horseradish peroxidase-linked antibodies (Sigma A6154) were used at a dilution of 1:50,000. The protein blots were visualized using SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Scientific). Quartz crystal microbalance. QCM measurements were performed using QCM-Z500 (KSV Instruments) and commercially available AT-cut polished QCM crystals with a fundamental resonant frequency of 4.95 MHz (International Crystal Manufacturing Co.) as reported previously 6 . The QCM crystal chips were pre-treated with anti-GFP antibody (Abcam ab290) to functionalize the chip surface. Subsequently, GFP-tagged receptors or GFP expressed in N. benthamiana and extracted as a microsomal fraction (for ER(DK)-GFP and TMM-GFP) or a total fraction (GFP) were immobilized onto a QCM sensor chip via anti-GFP antibody linkage. The chips were washed with a phosphate buffer extensively. After establishing a stable baseline using phosphate buffer solution, purified bioactive mEPF2 or Stomagen peptides in the phosphate buffer was added stepwise to the QCM chamber. The frequency change for QCM was monitored until no further change was observed, indicating equilibrium. All experiments were performed at 4 uC in stop-flow mode. The peptide-receptor binding was quantified via QCM by measuring the frequency shifts, DF, at several peptide concentrations. To determine the dissociation constant (K d ) of each peptide-receptor pair, the experimental frequency shift values were fitted to the Langmuir adsorption model: 2DF 5 DF max C/(C 1 K d ), where DF max is the frequency shift when the binding is saturated and C is the concentration of the bulk solution, using a least squares regression. Ligand competition assays. N. benthamiana leaves expressing CaMV35S:: ER(DK)-GFP were ground in liquid nitrogen and homogenized in extraction buffer (100 mM Tris-HCl pH 8.8, 150 mM NaCl, 1 mM EDTA, 20% glycerol, 20 mM NaF, 1 mM PMSF, 1:1,000 Complete protease inhibitor cocktail (Roche Applied Science)). The slurry was centrifuged at 10,000g for 15 min at 4 uC. The supernatant was sonicated on ice and then centrifuged at 100,000g for 30 min at 4 uC to give a pellet of the microsomal fractions. The pellet was resuspended in membrane solubilization buffer (100 mM Tris-HCl at pH 7.3, 150 mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100, 20 mM NaF, 1 mM RESEARCH ARTICLE PMSF, 1:1,000 Complete protease inhibitor cocktail) to release membrane proteins. The solution was sonicated on ice and centrifuged again at 100,000g for 30 min at 4 uC. The supernatant was incubated with Protein-G-coupled magnetic beads (Dynabeads Protein G, Invitrogen) that captured anti-GFP (ab290; Abcam) antibody at 4 uC for 2 h with gentle agitation. Then, the beads were washed four times with 500 ml of phosphate buffer (pH 7.4). The immunoprecipitates were suspended in 500 ml of binding buffer (50 mM MES-KOH, pH 5.5 with 100 mM sucrose) containing 1 mM mEPF2-MYC-HIS peptide in the absence or presence of different concentration of unlabelled bioactive Stomagen peptide and then incubated at 4 uC for 1 h with gentle agitation. The reaction mixture was washed four times with 500 ml of phosphate buffer (pH 7.4) to separate bound and free mEPF2-MYC-His peptide, and precipitated proteins were eluted with 23 SDS sample buffer at 80 uC for 5 min. Either total membrane or immunoprecipitated proteins were separated on a SDS-PAGE gel and transferred to PDVF membrane (Millipore) for immunoblot analysis using monoclonal anti-GFP (C163, 1:1,000, Invitrogen), anti-MYC (ab32, 1:1,000, abcam) or anti-Stomagen antibodies (1: 5,000, a gift from I. Hara-Nishimura) 13 as primary antibodies. As secondary antibodies, either goat anti-mouse or rabbit IgG horseradish peroxidase-linked antibodies (GE Healthcare NA931; Sigma A6154) were used at a dilution of 1:50,000. Co-immunoprecipitated mEPF2 was detected first. Then, the same blot was re-probed with anti-Stomagen antibody to detect Stomagen.
Four biological replicates were performed and subjected to quantification of the IC 50 values as the following. Band intensities on western blots were quantified using IMAGEJ (http://rsb.info.nih.gov/ij/index.html). Pixel values were measured on equal-sized areas and normalized against the bands detecting same immunoprecipitates by monoclonal anti-GFP antibody. The intensity values shown in the paper are the ratios relative to the references, and values were analysed by nonlinear regression analysis using OriginLab version 6 (OriginLab) to calculate the IC 50 value.
MAPK phosphorylation assays. 12-day-old Arabidopsis seedlings were grown for 5 days on 0.5 MS media plates and then transferred to 0.5 MS liquid media in a 12-well cluster plate (Falcon 3047). Seedlings were treated with buffer only, mEPF2 (2.5 mM), or with Stomagen (5 mM) at room temperature before being pooled for harvest. For heat denaturation of mEPF2, the peptide solution was treated at 95 uC for 2 h before MAPK phosphorylation assays and bioassays. Plant materials were ground in liquid nitrogen, and then extracted with buffer (100 mM HEPES, pH 7.5, 5 mM EDTA, 5 mM EGTA, 2 mM DTT, 10 mM Na 3 VO 4 , 10 mM NaF, 50 mM b-glycerolphosphate, 1 mM PMSF, 1 tablet per 50 ml extraction buffer of proteinase inhibitor mixture, 10% glycerol, 7.5% (w/v) PVPP). After centrifugation at 13,000 r.p.m. for 30 min, the protein concentration was determined using a Bradford assay (Bio-Rad). Immunoblot analysis was performed using anti-phospho-ERK (1:2,000, Cell Signaling) antibody as primary antibody, and peroxidase-conjugated goat anti-rabbit IgG (1:15,000, Sigma) as secondary antibody. c, Expression of EPF1, EPF2, total STOMAGEN and STOMAGEN transgene (iSTOMAGEN) transcripts in transgenic Est::STOMAGEN lines (in two different T1 populations (s1 and s2) and a representative T3 line (s3)) with or without oestradiol induction. STOMAGEN overexpression by oestradiol causes modest increase in EPF1 and EPF2 transcripts, which accords with increased stomatal differentiation by iSTOMAGEN. d, EPF1, EPF2 and STOMAGEN transcript accumulation in wild-type (wt) and single-and higher-order loss-offunction mutants of epf1, epf2 and stomagen (STOMAGEN-ami). For epf1 STOMAGEN-ami and epf2 STOMAGEN-ami lines, two different F 3 populations derived from the same genetic crosses were used to test the reproducibility. STOMAGEN expression is not influenced by epf1 and epf2 mutations, consistent with the proto-mesophyll expression of STOMAGEN. However, EPF2 expression is reduced by STOMAGEN-ami, consistent with reduced stomatal cell lineages by STOMAGEN co-suppression. As reported, epf1 has a T-DNA insertion within the 59 UTR 3 , which results in accumulation of aberrant transcripts. For all experiments, elF4A was used as a control. For primer sequences see Extended Data Table 1 .
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Extended Data Figure 3 | STOMAGEN overexpression promotes stomatal differentiation in genetic backgrounds missing/blocking EPF2-ER and EPF1-ERL1 signalling components. a-j, Representative confocal images of cotyledon abaxial epidermis from 10-day-old light-grown transgenic seedlings of the following genotypes, each carrying Est::STOMAGEN construct: epf2 (a, b); dominant-negative ER (ER(DK)) in er (c, d); epf1 (e, f); dominantnegative ERL1 (ERL1(DK)) in erl1 (g, h); er erl1 erl2 (i, j). For each genotype, a control uninduced phenotype (a, c, e, g, i) and induced STOMAGEN overexpression (iSTOMAGEN) (b, d, f, h, j) are shown. Blocking ER or lacking EPF2 produces small stomatal-lineage cells due to excessive entry divisions (a, c; yellow brackets). iSTOMAGEN confers stomatal clusters and small stomatal-lineage cells are no longer present (b and d). Blocking ERL1 or lacking EPF1 causes a stomatal pairing due to a violation of one-cell-spacing rule (e, g; dots). iSTOMAGEN enhances stomatal cluster phenotype in these genotypes (f, h). iSTOMAGEN does not enhance stomatal clustering defects in er erl1 erl2 (i, j). Images were taken under the same magnification. Scale bars, 30 mm. n 5 29 (a); n 5 24 (b); n 5 16 (c); n 5 17 (d); n 5 22 (e); n 5 23 (f); n 5 17 (g); n 5 20 (h); n 5 24 (i); n 5 24 (j 
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Extended Data Figure 6 | Association of Stomagen with ER-family receptors and TMM. a, Shown are co-immunoprecipitation assays of ligandreceptor pairs expressed in N. benthamiana leaves. The ectodomains and membrane-spanning domains of ER, ERL1 and ERL2 fused with GFP were separately expressed in N. benthamiana, and microsomal fractions were incubated with 1 mM Stomagen peptides followed by immunoprecipitation using anti-GFP (anti-GFP) antibody. Inputs and immunoprecipitates were immunoblotted using anti-GFP (anti-GFP) or anti-Stomagen (anti-Stomagen) antibodies. Experiments were repeated three times (three biological replicates). b, Co-immunoprecipitation of LURE2 peptide fused with hexa-histidine tag (LURE2-His) with N. benthamiana microsomal fractions expressing the ectodomains and membrane-spanning domains of ER and FLS2 fused with GFP, a full-length TMM fused with GFP, or a control, uninoculated leaf sample. Immunoprecipitation was performed using anti-GFP and immunoblotted using anti-GFP (for detection of receptors) or anti-His (for detection of LURE2-His) antibodies. Experiments were repeated twice (two biological replicates). c, Co-immunoprecipitation of Stomagen peptide with N. benthamiana microsomal fractions expressing the ectodomains and membrane-spanning domains of ER and FLS2 fused with GFP or a control, uninoculated leaf sample. Immunoprecipitation was performed using anti-GFP and immunoblotted using anti-GFP (for detection of receptors) or anti-Stomagen antibodies. Experiments were repeated four times (four biological replicates).
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Extended Data Figure 7 | Purified mEPF2 and Stomagen recombinant peptides and separation of bioactive mEPF2 by reverse-phase chromatography. a, SDS-PAGE gel of purified and refolded mEPF2-MYC-HIS and Stomagen recombinant peptides (asterisks). Left: molecular mass markers. b, HPLC chromatogram of purified, refolded mEPF2. Peaks 1 and 2 in UV chromatogram were collected and subjected to bioassays. c, Confocal image of cotyledon epidermis from wild-type seedling grown a solution with peak 1 for 5 days. No stoma is visible, indicating that peak 1 contains bioactive mEPF2. Scale bar, 20 mm. n 5 19. d, Confocal image of cotyledon epidermis from wild-type seedling grown in a solution with peak 2 for 5 days, with normal stomatal differentiation, indicating that the peptide is not bioactive. Scale bar, 20 mm. n 5 9.
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Extended Data Figure 8 | Separation of properly folded, bioactive Stomagen and mutant Stomagen peptides by reverse-phase chromatography followed by mass spectrometry and bioassays. a, HPLC chromatogram of purified, refolded Stomagen. Peaks 1 and 2 in UV chromatogram were collected and subjected to MALDI-TOF mass spectrometry (b, d) as well as for bioassays (c, e). b, MALDI-TOF spectrum of peak 1 from a. A single-charged peptide corresponding to synthetic Stomagen peptide was observed at m/z 5 5,118.5 ([M1H] 1 ) and a double charged peptide at m/z 5 2,559.8 ([M12H] 21 ). c, Confocal image of cotyledon epidermis from wild-type seedling grown a solution with peak 1. Severe stomatal clustering and overproduction of stomata are observed. Scale bar, 20 mm. n 5 8. d, MALDI-TOF spectrum of peak 2 from a. e, Confocal image of cotyledon epidermis from wild-type seedling grown in a solution with peak 2 from a, with no stomatal clustering, indicating that the fraction is not bioactive. Scale bar, 20 mm. n 5 6. f, HPLC chromatogram and bioassays of an independent batch of Stomagen peptides used for QCM analysis in direct comparison with non-folding mutant Stomagen peptides in Fig. 3c . Peaks 1 and 2 in UV chromatogram were collected and subjected for bioassays. Insets: confocal microscopy images of cotyledon epidermis from wild-type seedling grown a solution with peak 1 (bioactive) and peak 2 (non-active) for 5 days. Scale bars, 50 mm. n 5 8 (peak 1); n 5 6 (peak 2). g, HPLC chromatogram of purified, mutant Stomagen peptide in which all cysteine residues were substituted to serine residues (Stomagen_6CRS). The mutant Stomagen peptide yielded a single peak, which was subjected for bioassays followed by confocal microscopy (inset). No stomatal clustering was observed, indicating that non-folding Stomagen peptide is not bioactive, confirming the previous results 18 . Scale bar, 50 mm. n 5 8 for each peptide treatment. Numbers of experiments performed for each analysis: Stomagen-ER, n 5 3; Stomagen-TMM, n 5 2; Stomagen-GFP, n 5 3; mEPF2-ER, n 5 2; mEPF2-TMM, n 5 3; mEPF2-GFP, n 5 2; inactive Stomagen_C6RS-ER, n 5 3; and LURE2-ER, n 5 2.
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